Neuroscience Antibodies & Assays Global Market Report 2025

Description

Neuroscience antibodies and assays play a crucial role in examining the development, systems, structure, function, disorders, and degeneration of the nervous system. Neuroscience, as a field, focuses on understanding the nervous system, its functioning, and disorders associated with it. Antibodies and assays, which are medical tests based on the interaction between antigenic epitopes and antibodies, find significant utility in neuroscience and the investigation of neurological disorders.

The primary categories of products in the neuroscience antibodies and assays market include consumables and instruments. Consumables, essential in numerous neurological studies and research experiments, comprise assay kits, reagents, and antibodies, facilitating quantitative and real-time live-cell analysis. Technologies employed in this domain encompass molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, and other relevant technologies. Applications of neuroscience antibodies and assays span in vitro diagnostics, research, and drug discovery. The end users of these products are diverse, including hospitals and diagnostics centers, academic and research institutes, as well as pharmaceutical and biotechnology companies.

The neuroscience antibodies & assays market research report is one of a series of new reports from The Business Research Company that provides neuroscience antibodies & assays market statistics, including neuroscience antibodies & assays industry global market size, regional shares, competitors with an neuroscience antibodies & assays market share, detailed neuroscience antibodies & assays market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience antibodies & assays industry. This neuroscience antibodies & assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroscience antibodies & assays market size has grown rapidly in recent years. It will grow from $4.52 billion in 2024 to $5.07 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to research funding, drug discovery and development, neurodegenerative diseases, government initiatives, personalized medicine.

The neuroscience antibodies & assays market size is expected to see rapid growth in the next few years. It will grow to $8.74 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to collaborations, telemedicine in neurology, education and training, biomarker-drivenTherapies, neuroimmunology focus. Major trends in the forecast period include microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, 3D organoid models.

The rising prevalence of neurological disorders worldwide is anticipated to drive the growth of the neuroscience antibodies and assays market in the coming years. Neurological disorders are conditions that affect the nervous system, with examples including epilepsy, Alzheimer's disease, and dementia. The increasing number of neurological illnesses necessitates greater research and development efforts for their treatment. Antibodies and assays play a crucial role in research and development activities by helping to investigate the development, systems, structure, function, and degeneration of the nervous system. Consequently, the neuroscience antibodies and assays market expands in tandem with the rising incidence of neurological disorders. For instance, in May 2024, data from the Centers for Disease Control and Prevention, a US federal agency, indicated that approximately 2.9 million adults in the U.S. aged 18 and older reported having active epilepsy during 2021 and 2022. Additionally, according to the Alzheimer's Association, a US-based non-profit organization, about 6.5 million individuals in the US were diagnosed with Alzheimer's disease as of 2022. Thus, the growing incidence of neurological disorders globally is propelling the neuroscience antibodies and assays market forward.

The expanding healthcare sector is projected to drive the growth of the neuroscience antibodies and assays market. The healthcare sector encompasses a network of organizations, institutions, professionals, and resources committed to delivering medical services, healthcare products, and support aimed at maintaining or enhancing people's health. Neuroscience antibodies and assays are widely utilized in this sector for various applications, owing to their capacity to detect and measure specific proteins, biomarkers, and molecular processes within the nervous system. For example, in December 2023, data from the Centers for Medicare & Medicaid Services, a US federal agency, revealed that U.S. healthcare spending rose by 4.1%, reaching $4.5 trillion in 2022, exceeding the 3.2% growth recorded in 2021. As a result, the increase in healthcare expenditures is boosting the nasal polyps treatment market. Consequently, the growth of the healthcare sector is expected to propel the neuroscience antibodies and assays market in the future.

A notable trend in the neuroscience antibodies and assays market is the adoption of technological advancements. Major market players are introducing innovative technologies, such as NeuroNexus Summa Framework, to enhance their market position. NeuroNexus Technologies, in February 2022, launched the Summa Framework technology, designed to facilitate electrical signal read-outs from biological cells and tissues for both experienced electrophysiologists and life science researchers. This technological advancement is contributing to the development and sustainability of the neuroscience antibodies and assays market.

Major companies operating in the neuroscience antibodies and assays market are focusing on developing innovative products. Product innovation involves a heightened emphasis on creating novel and advanced products to support neuroscience research and diagnostics. For instance, Labcorp, in July 2022, introduced the Neurofilament Light Chain (NFL) blood test, enabling physicians to detect and confirm indicators of neurodegenerative diseases. This test enhances diagnostic capabilities, potentially improving the diagnosis, treatment, and management of neurological disorders.

In June 2022, Fujirebio, a multinational biotechnology company based in Japan, acquired ADx NeuroSciences to expand its global offering of neurodegenerative disease diagnostic solutions. ADx Neurosciences, based in Belgium, specializes in developing tailor-made antibodies and assays for pharma and in vitro diagnostics companies.

Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in neuroscience antibodies & assays market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the neuroscience antibodies & assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The neuroscience antibodies & assays market consists of sales of antibodies and assay kits and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroscience Antibodies & Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroscience antibodies & assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroscience antibodies & assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroscience antibodies & assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Consumables; Instruments
2) By Technology: Molecular Diagnostics; Clinical Chemistry; Immunoassays Or Immunochemistry; Others Technologies
3) By Application: In Vitro Diagnostics; Research; Drug Discovery
4) By End User: Hospitals And Diagnostics Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Consumables: Antibodies; Assay Kits; Assay Kits
2) By Instruments: Spectrophotometers; Microplate Readers; Flow Cytometers; Western Blotting Systems; Imaging Systems; Automated Workstations
Companies Mentioned: Abcam plc; BioLegend Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; F. Hoffmann-La Roche AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r21851

1. Executive Summary

2. Neuroscience Antibodies & Assays Market Characteristics

3. Neuroscience Antibodies & Assays Market Trends And Strategies

4. Neuroscience Antibodies & Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Neuroscience Antibodies & Assays Growth Analysis And Strategic Analysis Framework

5.1. Global Neuroscience Antibodies & Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neuroscience Antibodies & Assays Market Growth Rate Analysis
5.4. Global Neuroscience Antibodies & Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neuroscience Antibodies & Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neuroscience Antibodies & Assays Total Addressable Market (TAM)

6. Neuroscience Antibodies & Assays Market Segmentation

6.1. Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Instruments
6.2. Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Diagnostics
Clinical Chemistry
Immunoassays Or Immunochemistry
Others Technologies
6.3. Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In Vitro Diagnostics
Research
Drug Discovery
6.4. Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostics Centers
Academic And Research Institutes
Pharmaceutical And Biotechnology Companies
6.5. Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibodies
Assay Kits
Assay Kits
6.6. Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spectrophotometers
Microplate Readers
Flow Cytometers
Western Blotting Systems
Imaging Systems
Automated Workstations

7. Neuroscience Antibodies & Assays Market Regional And Country Analysis

7.1. Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuroscience Antibodies & Assays Market

8.1. Asia-Pacific Neuroscience Antibodies & Assays Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuroscience Antibodies & Assays Market

9.1. China Neuroscience Antibodies & Assays Market Overview
9.2. China Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuroscience Antibodies & Assays Market

10.1. India Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuroscience Antibodies & Assays Market

11.1. Japan Neuroscience Antibodies & Assays Market Overview
11.2. Japan Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuroscience Antibodies & Assays Market

12.1. Australia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuroscience Antibodies & Assays Market

13.1. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuroscience Antibodies & Assays Market

14.1. South Korea Neuroscience Antibodies & Assays Market Overview
14.2. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuroscience Antibodies & Assays Market

15.1. Western Europe Neuroscience Antibodies & Assays Market Overview
15.2. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuroscience Antibodies & Assays Market

16.1. UK Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuroscience Antibodies & Assays Market

17.1. Germany Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuroscience Antibodies & Assays Market

18.1. France Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuroscience Antibodies & Assays Market

19.1. Italy Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuroscience Antibodies & Assays Market

20.1. Spain Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuroscience Antibodies & Assays Market

21.1. Eastern Europe Neuroscience Antibodies & Assays Market Overview
21.2. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuroscience Antibodies & Assays Market

22.1. Russia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuroscience Antibodies & Assays Market

23.1. North America Neuroscience Antibodies & Assays Market Overview
23.2. North America Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuroscience Antibodies & Assays Market

24.1. USA Neuroscience Antibodies & Assays Market Overview
24.2. USA Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuroscience Antibodies & Assays Market

25.1. Canada Neuroscience Antibodies & Assays Market Overview
25.2. Canada Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuroscience Antibodies & Assays Market

26.1. South America Neuroscience Antibodies & Assays Market Overview
26.2. South America Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuroscience Antibodies & Assays Market

27.1. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuroscience Antibodies & Assays Market

28.1. Middle East Neuroscience Antibodies & Assays Market Overview
28.2. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuroscience Antibodies & Assays Market

29.1. Africa Neuroscience Antibodies & Assays Market Overview
29.2. Africa Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuroscience Antibodies & Assays Market Competitive Landscape And Company Profiles

30.1. Neuroscience Antibodies & Assays Market Competitive Landscape
30.2. Neuroscience Antibodies & Assays Market Company Profiles
- 30.2.1. Abcam plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BioLegend Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Cell Signaling Technology Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. Neuroscience Antibodies & Assays Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific
31.2. Merck KGaA
31.3. Rockland Immunochemicals Inc.
31.4. GenScript Biotech Corporation
31.5. Santa Cruz Biotechnology Inc.
31.6. Wak-Chemie Medical GmbH
31.7. Epitope Diagnostics Inc.
31.8. Agilent Technologies
31.9. Bio-Techne Corporation
31.10. Creative Diagnostics
31.11. Enzo Life Sciences Inc.
31.12. Jackson ImmunoResearch Laboratories Inc.
31.13. Novus Biologicals LLC
31.14. OriGene Technologies Inc.
31.15. Proteintech Group Inc.

32. Global Neuroscience Antibodies & Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroscience Antibodies & Assays Market

34. Recent Developments In The Neuroscience Antibodies & Assays Market

35. Neuroscience Antibodies & Assays Market High Potential Countries, Segments and Strategies

35.1 Neuroscience Antibodies & Assays Market In 2029 - Countries Offering Most New Opportunities
35.2 Neuroscience Antibodies & Assays Market In 2029 - Segments Offering Most New Opportunities
35.3 Neuroscience Antibodies & Assays Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer